Results Among the 56,908 individuals with T1DM, 10,822 (19.0%) used CGM at least once, and 6,073 (10.7%) used CGM continuously
Garcia-Segura LM, Arevalo MA, Azcoitia I: Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances
The key is to keep it away from heat, direct light, and moisture
Each pen is intended for click-dosed administration without end-user reconstitution
Long-acting IGF-1 activity Reduced IGFBP binding leaves more available, giving a longer half-life and about three times the potency of native IGF-1
Check out our Wholesale Orders Page to SAVE up to 50%